Cellular uptake of magnetic nanoparticles quantified by magnetic particle spectroscopy

IEEE Transactions on Magnetics

Volumn 49, Issue 1, 2013, Pages 275-278

  Loewa, Norbert ^a   Wiekhorst, Frank ^a   Gemeinhardt, Ines ^b   Ebert, Monika ^b   Schnorr, Joerg ^b   Wagner, Susanne ^b   Taupitz, Matthias ^b   Trahms, Lutz ^a  

^a PHYSIKALISCH TECHNISCHE BUNDESANSTALT   (Germany)

^b CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

Cellular uptake; magnetic nanoparticles (MNPs); magnetic particle spectroscopy (MPS); quantification

Indexed keywords

BIOMEDICAL APPLICATIONS; BRUKER BIOSPIN; CELLULAR UPTAKE; DRUG-TARGETING; MAGNETIC IRON OXIDE NANOPARTICLES; MAGNETIC NANOPARTICLES; MAGNETIC PARTICLE; MAGNETOFECTION; NON-LINEAR RESPONSE; QUANTIFICATION; SINUSOIDAL EXCITATIONS;

MEDICAL APPLICATIONS; NANOPARTICLES; PARTICLE SPECTROMETERS; TISSUE;

NANOMAGNETICS;

EID: 84871845838     PISSN: 00189464     EISSN: None     Source Type: Journal    
DOI: 10.1109/TMAG.2012.2218223     Document Type: Article

References (33)

1. A. K. Gupta and M. Gupta, "Synthesis and surface engineering of iron oxide nanoparticles for biomedical application," Biomaterials, vol. 26, no. 18, pp. 3995-4021, Jun. 2005. (Pubitemid 40044762)
2. Q. A. Pankhurst, J. Connolly, S. K. Jones, and J. Dobson, "Applications ofmagnetic nanoparticles in biomedicine," J. Phys. D: Appl. Phys., vol. 36, no. 13, pp. 167-181, Jun. 2003.
3. L. Trahms, "Biomedical applications of magnetic nanoparticles," in ColloidalMagnetic Fluids, Lecture Notes in Physics: Basics, Development and Application of Ferrofluids, S. Odenbach, Ed., 1st ed. Berlin: Springer, 2009, vol. 763, pp. 1-32.
4. K. M. Krishnan, "Biomedical nanomagnetics: A spin through possibilities in imaging, diagnostics, and therapy," IEEE Trans. Magn., vol. 46, no. 7, pp. 2523-2558, Jul. 2010.
5. P. Tartaj, M. d. P. Morales, S. Veintemillas-Verdaguer, T. Gonzáles-Carreño, and C. J. Serna, "The preparation of magnetic nanoparticles for applications in biomedicine," J. Phys. D: Appl. Phys., vol. 36, no. 13, pp. R182-R197, Nov. 2003.
6. C. Plank, U. Schillinger, F. Scherer, C. Bergemann, J.-S. Rémy, F. Krötz, M. Anton, J. Lausier, and J. Rosenecker, "The magnetofection method: Using magnetic force to enhance gene delivery," J. Biol. Chem., vol. 384, no. 5, pp. 737-747, May 2003. (Pubitemid 36747935)
7. O. Mykhaylyk, O. Zelphati, E. Hammerschmid, M. Anton, J. Rosenecker, and C. Plank, "Recent advances in magnetofection and its potential to deliver siRNAs in vitro," Methods Mol. Biol., vol. 487, pp. 111-146, Apr. 2009.
8. J. H. Clement, M. Schwalbe, N. Buske, K. Wagner, M. Schnabelrauch, P. Görnert, K. O. Kliche, K. Pachmann, W. Weitschies, and K. Höffken, "Differential interaction ofmagnetic nanoparticleswith tumor cells and peripheral blood cells," J. Cancer Res. Clin. Oncol., vol. 132, no. 5, pp. 287-292, May 2006.
9. C. Alexiou, R. Jurgons, C. Seliger, O. Brunke, H. Iro, and S. Odenbach, "Delivery of superparamagnetic nanoparticles for local chemotherapy after intraarterial infusion and magnetic drug targeting," Anticancer Res., vol. 27, no. 4, pp. 2019-2022, Jul.-Aug. 2007. (Pubitemid 46954718)
10. B. Polyak and G. Friedman, "Magnetic targeting for site-specific drug delivery: Applications and clinical potential," Expert Opin. Drug Deliv., vol. 6, no. 1, pp. 53-70, Jan. 2009.
11. A. P. Khandhar, R. M. Ferguson, J. A. Simon, and K. M. Krishnan, "Tailored magnetic nanoparticles for optimizing magnetic fluid hyperthermia," J. Biomed. Mater. Res. A, vol. 100, no. 3, pp. 728-737, Mar. 2012.
12. I. Hilger, R. Hergt, and W. A. Kaiser, "Effects of magnetic thermoablation in muscle tissue using iron oxide particles: An in vitro study," Invest. Radiol., vol. 35, no. 3, pp. 170-179, Mar. 2000. (Pubitemid 30389716)
13. C. E. Neumaier, G. Baio, S. Ferrini, G. Corte, and A. Daga, "MR and iron magnetic nanoparticles. Imaging opportunities in preclinical and translational research," Tumori, vol. 94, no. 2, pp. 226-233, Mar.-Apr. 2008. (Pubitemid 351838830)
14. B. Gleich and J. Weizenecker, "Tomographic imaging using the nonlinear response of magnetic nanoparticles," Nature, vol. 435, no. 7046, pp. 1214-1217, Jun. 2005. (Pubitemid 40943083)
15. S. Boutry, D. Forge, C. Burtea, I. Mahieu, O. Murariu, S. Laurent, E. L. Vander, and R. N. Muller, "How to quantify iron in an aqueous or biological matrix: A technical note," Contrast Media Mol. Imag., vol. 4, no. 6, pp. 299-304, Nov.-Dec. 2009.
16. D. J. Maxwell, J. Bonde, D. A. Hess, S. A. Hohm, and R. Lahey, "Fluorophore-conjugated iron oxide nanoparticle labeling and analysis of engrafting human hematopoietic stem cells," Stem Cells, vol. 26, no. 2, pp. 517-524, Feb. 2008. (Pubitemid 351413612)
17. S. Liang, Y. Wang, J. Yu, C. Zhang, J. Xia, and D. Yin, "Surface modified superparamagnetic iron oxide nanoparticles: As a new carrier for bio-magnetically targeted therapy," J. Mater. Sci. Mater. Med., vol. 18, no. 12, pp. 2297-2302, Dec. 2007. (Pubitemid 350165598)
18. J. W. Bulte, "In vivo MRI cell tracking: Clinical studies," AJR Am. J. Roentgenol., vol. 193, no. 2, pp. 314-325, Aug. 2009.
19. E. Wuerfel, M. Smyth, J. M. Millward, E. Schellenberger, J. Glumm, T. Prozorovski, O. Aktas, U. Schulze-Topphoff, J. Schnorr, S. Wagner, M. Taupitz, C. Infante-Duarte, and J. Wuerfel, "Electrostatically stabilized magnetic nanoparticles-An optimized protocol to labelmurine T cells for in vivo MRI," Front. Neurol., vol. 2, p. 72, Dec. 2011.
20. T. G. St Pierre, P. R. Clark, W. Chua-anusorn, A. J. Fleming, H. R. Pardoe, G. P. Jeffrey, J. K. Olynyk, P. Pootrakul, S. Jones, and P. Moroz, "Non-invasive measurement and imaging of tissue iron oxide nanoparticle concentrations in vivo using proton relaxometry," J. Phys.: Conf. Ser., vol. 17, pp. 122-126, Jan. 2005. (Pubitemid 41204731)
21. M. Taupitz, S. Wagner, J. Schnorr, I. Kravec, H. Pilgrimm, H. Bergmann-Fritsch, and B. Hamm, "Phase I clinical evaluation of citrate-coated monocrystalline very small superparamagnetic iron oxide particles as a new contrast medium for magnetic resonance imaging," Invest. Radiol., vol. 39, no. 7, pp. 394-405, Jul. 2004. (Pubitemid 38802814)
22. F. Wiekhorst, U. Steinhoff, D. Eberbeck, and L. Trahms, "Magnetorelaxometry assisting biomedical applications of magnetic nanoparticles," Pharm. Res., vol. 29, no. 5, pp. 1189-1202, May 2012.
23. P. Danhier, G. De Preter, S. Boutry, I. Mahieu, P. Leveque, J. Magat, V. Haufroid, P. Sonveaux, C. Bouzin, O. Feron, R. N. Muller, B. F. Jordan, and B. Gallez, "Electron paramagnetic resonance as a sensitive tool to assess the iron oxide content in cells forMRI cell labeling studies," ContrastMedia Mol. Imag., vol. 7, no. 3, pp. 302-307, May.-Jun. 2012.
24. L. Gutiérrez, R. Mejías, D. F. Barber, S. Veintemillas-Verdaguer, C. J. Serna, F. J. Lázaro, and M. P. Morales, "AC Magnetic susceptibility study of in vivo nanoparticle biodistribution," J. Phys. D: Appl. Phys., vol. 44, no. 25, pp. 255002-255010, Jun. 2011.
25. M. Visscher, M. Holling, J. Pouw, and B. T. Haken, "A magnetometer cooled with liquid nitrogen for the characterization and quantification of magnetic nanoparticles in biological tissue at room temperature," in Magnetic Particle Imaging: A Novel SPIO Nanoparticle Imaging Technique, T. M. Buzug and J. Borgert, Eds. Berlin: Springer, 2012, vol. 140, p. 377.
26. D. Eberbeck, A. P. Astalan, K. Petersson, F. Wiekhorst, C. Bergemann, C. Johansson, U. Steinhoff, H. Richter, A. Krotzer, and L. Trahms, "AC susceptometry and magnetorelaxometry for magnetic nanoparticle based biomolecule detection," in Proc. 4th Eur. Conf. Int. Federation Med. Biol. Eng., J. van der Sloten, P. Verdonck, M. Nyssen, and J. Haueisen, Eds., Berlin, 2009, vol. 22, pp. 2317-2321, Springer.
27. D. Eberbeck, F. Wiekhorst, S. Wagner, and L. Trahms, "How the size distribution of magnetic nanoparticles determines their magnetic particle imaging performance," Appl. Phys. Lett., vol. 98, no. 18, pp. 182502-182505, May 2011.
28. S. R. Snyder and U. Heinen, Characterization of Magnetic Nanoparticles for Therapy and Diagnostics [Online]. Available: http://www. bruker-biospin. com/mps-apps. html [Accessed: 01-Jul-2012]
29. B. S. Spinowitz, A. T. Kausz, J. Baptista, S. D. Noble, R. Sothinathan, M. V. Bernardo, L. Brenner, and B. J. G. Pereira, "Ferumoxytol for treating iron deficiency anemia in CKD," J. Am. Soc. Nephrol., vol. 19, no. 8, pp. 1599-1605, Aug. 2008.
30. W. Li, S. Tutton, A. T. Vu, L. Pierchala, B. S. Y. Li, J. M. Lewis, P. V. Prasad, and R. R. Edelman, "First-pass contrast-enhanced magnetic resonance angiography in humans using ferumoxytol, a novel ultrasmall superparamagnetic iron oxide (USPIO)-based blood pool agent," J. Magn. Reson. Imag., vol. 21, no. 1, pp. 46-52, Jan. 2005. (Pubitemid 40041419)
31. A. M. Rauwerdink and J. B. Weaver, "Harmonic phase angle as a concentration-independent measure of nanoparticle dynamics," Med. Phys., vol. 37, no. 6, pp. 2587-2592, Jun. 2010.
32. D. Eberbeck, F. Wiekhorst, U. Steinhoff, and L. Trahms, "Aggregation behaviour of magnetic nanoparticle suspensions investigated by magnetorelaxometry," J. Phys.: Condensed Matter, vol. 18, no. 38, pp. S2829-S2846, Sep. 2006. (Pubitemid 44523004)
33. D. Eberbeck, C. Bergemann, F. Wiekhorst, U. Steinhoff, and L. Trahms, "Quantification of specific bindings of biomolecules by magnetorelaxometry," J. Nanobiotechnology, vol. 6, no. 1, p. 4, Mar. 2008.